BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33496821)

  • 1. Do Black and Asian individuals wait longer for treatment? A survival analysis investigating the effect of ethnicity on time-to-clinic and time-to-treatment for diabetic eye disease.
    Kirthi V; Reed KI; Gunawardena R; Alattar K; Bunce C; Jackson TL
    Diabetologia; 2021 Apr; 64(4):749-757. PubMed ID: 33496821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black patients sustain vision loss while White and South Asian patients gain vision following delamination or segmentation surgery for tractional complications associated with proliferative diabetic retinopathy.
    Mastropasqua R; Luo YH; Cheah YS; Egan C; Lewis JJ; da Cruz L
    Eye (Lond); 2017 Oct; 31(10):1468-1474. PubMed ID: 28574495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic variation in the prevalence of visual impairment in people attending diabetic retinopathy screening in the United Kingdom (DRIVE UK).
    Sivaprasad S; Gupta B; Gulliford MC; Dodhia H; Mann S; Nagi D; Evans J
    PLoS One; 2012; 7(6):e39608. PubMed ID: 22761840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study.
    Chew EY; Ferris FL; Csaky KG; Murphy RP; Agrón E; Thompson DJ; Reed GF; Schachat AP
    Ophthalmology; 2003 Sep; 110(9):1683-9. PubMed ID: 13129862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Diabetic Retinopathy, Visual Acuity, and Treatment Outcomes for Patients Living With Diabetes in a Fundus Photograph-Based Diabetic Retinopathy Screening Program in Bangladesh.
    Muqit MMK; Kourgialis N; Jackson-deGraffenried M; Talukder Z; Khetran ER; Rahman A; Chan WO; Chowdury FA; Nag D; Ahmad J; Friedman DS
    JAMA Netw Open; 2019 Nov; 2(11):e1916285. PubMed ID: 31774523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy equity profile in a multi-ethnic, deprived population in Northern England.
    Kliner M; Fell G; Gibbons C; Dhothar M; Mookhtiar M; Cassels-Brown A
    Eye (Lond); 2012 May; 26(5):671-7. PubMed ID: 22302063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
    Baker CW; Glassman AR; Beaulieu WT; Antoszyk AN; Browning DJ; Chalam KV; Grover S; Jampol LM; Jhaveri CD; Melia M; Stockdale CR; Martin DF; Sun JK;
    JAMA; 2019 May; 321(19):1880-1894. PubMed ID: 31037289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial, Ethnic, and Insurance-Based Disparities Upon Initiation of Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in the US.
    Malhotra NA; Greenlee TE; Iyer AI; Conti TF; Chen AX; Singh RP
    Ophthalmology; 2021 Oct; 128(10):1438-1447. PubMed ID: 33716048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services.
    Denniston AK; Lee AY; Lee CS; Crabb DP; Bailey C; Lip PL; Taylor P; Pikoula M; Cook E; Akerele T; Antcliff R; Brand C; Chakravarthy U; Chavan R; Dhingra N; Downey L; Eleftheriadis H; Ghanchi F; Khan R; Kumar V; Lobo A; Lotery A; Menon G; Mukherjee R; Palmer H; Patra S; Paul B; Sim DA; Talks JS; Wilkinson E; Tufail A; Egan CA;
    Br J Ophthalmol; 2019 Jun; 103(6):837-843. PubMed ID: 30269098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does delay in referral of proliferative diabetic retinopathy from the diabetic eye screening programme lead to visual loss?
    Negretti GS; Amin R; Webster L; Egan CA
    Eye (Lond); 2016 Jun; 30(6):873-6. PubMed ID: 27055673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
    JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year recall for people with no diabetic retinopathy: a multi-ethnic population-based retrospective cohort study using real-world data to quantify the effect.
    Olvera-Barrios A; Rudnicka AR; Anderson J; Bolter L; Chambers R; Warwick AN; Welikala R; Fajtl J; Barman S; Remgnino P; Wu Y; Lee AY; Chew EY; Ferris FL; Hingorani A; Sofat R; A Egan C; Tufail A; Owen CG;
    Br J Ophthalmol; 2023 Nov; 107(12):1839-1845. PubMed ID: 37875374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ethnicity and other sociodemographic factors on attendance at diabetic eye screening: a 12-month retrospective cohort study.
    Olvera-Barrios A; Seltene M; Heeren TFC; Chambers R; Bolter L; Tufail A; Owen CG; Rudnicka AR; Egan C; Anderson J
    BMJ Open; 2021 Sep; 11(9):e046264. PubMed ID: 34535475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK study.
    Gupta B; Sivaprasad S; Wong R; Laidlaw A; Jackson TL; McHugh D; Williamson TH
    Eye (Lond); 2012 Apr; 26(4):510-6. PubMed ID: 22222268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roadmap to close the gap for vision--diabetes-related eye care in the Indigenous Australian population.
    Tapp RJ; Anjou MD; Boudville AI; Taylor HR
    Diabet Med; 2013 Sep; 30(9):1145-6. PubMed ID: 23586406
    [No Abstract]   [Full Text] [Related]  

  • 16. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
    Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
    PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and determinants of undiagnosed diabetic retinopathy and vision-threatening retinopathy in a multiethnic Asian cohort: the Singapore Epidemiology of Eye Diseases (SEED) study.
    Huang OS; Tay WT; Ong PG; Sabanayagam C; Cheng CY; Tan GS; Cheung GC; Lamoureux EL; Wong TY
    Br J Ophthalmol; 2015 Dec; 99(12):1614-21. PubMed ID: 25953847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.